When Rigid Arteries Rob the Brain: HIV’s Double Hit

Key Takeaway: In a study of over 700 men, stiffer carotid arteries were significantly associated with slower processing speed and impaired executive function, particularly in men living with HIV. The findings reinforce that aggressive management of cardiovascular risk factors in individuals with HIV is crucial not only for heart health but also for preserving long-term cognitive function.

When Stiff Arteries Slow the Mind

For men living with HIV, the health of their carotid arteries—the two major vessels running up each side of the neck that supply oxygen-rich blood to the brain—may be a direct reflection of their brain health. Stiffened arteries, it turns out, are linked to slower cognitive processing speed. This connection, known in the general aging population, appears to carry a particular burden for individuals grappling with a chronic viral infection that already lays siege to the brain.

Thanks to antiretroviral therapy, HIV has shifted from a terminal diagnosis to a manageable chronic condition. But this success in survival has brought a new clinical frontier: the long-term complications of living with the virus for decades. Among the most concerning is the phenomenon of “accelerated aging,” where people with HIV develop age-related diseases like cardiovascular disease and cognitive impairment earlier and more aggressively than their HIV-negative peers^[2]. A new analysis from the Multicenter AIDS Cohort Study (MACS) draws a direct line between two of these complications, linking vascular stiffness in the neck to measurable cognitive slowing.

Study Methodology

The study drew on data from 717 men enrolled in MACS, a long-running U.S. cohort study that has tracked the health of men who have sex with men since the early years of the HIV epidemic. Of the participants, 459 were living with HIV, and 258 were HIV-negative. Using ultrasound, researchers measured carotid artery distensibility—how much the arterial wall stretches and recoils with each heartbeat. An artery with high distensibility is elastic and healthy; a stiff artery with low distensibility is a vessel that has lost its youthful pliability, often due to atherosclerosis, chronic inflammation, or aging.

Participants also completed a battery of neuropsychological tests targeting psychomotor speed (how quickly the brain coordinates thought and movement) and executive function (higher-level cognitive skills like planning, decision-making, and mental flexibility). The researchers then created statistical models adjusted for a wide range of potential confounding factors, including age, education, blood pressure, diabetes, smoking, and use of cardiovascular medications.

Findings

In analyses adjusted for all variables, lower carotid artery distensibility—meaning stiffer arteries—was significantly associated with slower performance on tests of psychomotor speed and executive function in men living with HIV^[1]. The relationship was specific and consistent: the stiffer the artery, the slower the cognitive performance. While similar trends were observed in HIV-negative men, the findings were weaker and did not reach statistical significance, possibly due to the smaller sample size in that group.

The implication is clear. Vascular aging may compound or accelerate the cognitive decline that can be caused by HIV alone, delivering a double blow to brain health that is greater than the sum of its parts.

The Mechanism: How Stiff Arteries Damage the Brain

To understand why a stiff carotid artery might slow down thinking, it helps to consider what healthy arteries do. With each heartbeat, the aorta and its main branches, including the carotid arteries, expand to absorb the pulse of blood ejected from the left ventricle. This “Windkessel” function smoothes out the pulsatile flow, transforming it into a gentler, more continuous stream by the time the blood reaches the tiny arterioles and capillaries within the brain^[3]. When the carotid artery stiffens, it loses this buffering capacity. High-pressure pulse waves are transmitted directly into the brain’s delicate microvascular network, damaging small vessels over time and impairing the delivery of oxygen and nutrients to neurons.

This process, sometimes called cerebral small vessel disease, manifests as white matter lesions, microbleeds, and eventual neuronal loss—all of which degrade cognitive processing speed and executive function^[4]. In the general population, arterial stiffness, measured by pulse wave velocity, has been shown to be independently associated with cognitive decline and risk of dementia^[5].

Now, add HIV to this picture. Even with well-controlled viral loads, HIV triggers persistent, low-grade systemic inflammation and immune activation. Elevated levels of inflammatory markers like interleukin-6, C-reactive protein, and D-dimer are common in people with HIV, and these mediators directly promote endothelial dysfunction and arterial stiffening^[6]. The virus itself, along with certain antiretroviral drugs, can alter lipid metabolism, further promoting atherogenesis. Meanwhile, HIV can cross the blood-brain barrier, establishing reservoirs in microglia and astrocytes, which perpetuates neuroinflammation independent of peripheral viral control^[7]. The result is a brain that is both under-nourished by stiff arteries and inflamed from within. This intersection may explain why the link between carotid stiffness and cognitive decline was statistically significant only in the HIV-positive group.

Study Limitations

Studies like this one can identify associations, but they cannot definitively prove that stiffened arteries directly cause cognitive decline. As the study included only men, the findings may not be generalizable to women living with HIV, who face their own unique cardiovascular and neurological risk profiles. The smaller size of the HIV-negative comparison group may have limited the statistical power to detect significant associations in that cohort. Furthermore, while the models adjusted for many confounders, unmeasured factors such as substance use patterns, mental health conditions, or specific antiretroviral regimens could influence the results.

Conclusion: Protecting the Brain by Protecting the Arteries

For clinicians following patients living with HIV, this study offers a tangible clinical message: vascular health is brain health, and this connection may be amplified in the setting of chronic HIV infection. Measuring and addressing modifiable cardiovascular risk factors—hypertension, dyslipidemia, smoking, diabetes, and physical inactivity—is not just about preventing heart attacks and strokes. It is about preserving the cognitive function that allows patients to manage complex medication regimens, maintain employment, and preserve their quality of life over decades of survival.

The takeaway for patients is equally clear. Blood pressure control, regular exercise, smoking cessation, and statin therapy when indicated are investments in long-term brain health. In a population already contending with the challenges of accelerated aging, these interventions may represent one of the most powerful tools available to keep the mind sharp as the body ages.

Scientific Sources

1. Jones R, et al. Carotid Artery Stiffness and Cognitive Performance among Men Living with and without HIV. The journals of gerontology. Series A, Biological sciences and medical sciences. 2026. PubMed: https://pubmed.ncbi.nlm.nih.gov/42690680/
2. Deeks SG, et al. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011. DOI: 10.1146/annurev-med-042909-093756
3. Westerhof N, et al. The arterial Windkessel. Med Biol Eng Comput. 2009. DOI: 10.1007/s11517-008-0359-2
4. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010. DOI: 10.1016/S1474-4422(10)70104-6
5. van Sloten TT, et al. Association between arterial stiffness and cognitive function: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2015. DOI: 10.1016/j.neubiorev.2015.03.011
6. Kuller LH, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008. DOI: 10.1371/journal.pmed.0050203
7. Heaton RK, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010. DOI: 10.1212/WNL.0b013e318200d727